{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:21:51Z","timestamp":1777958511426,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["NS112327"],"award-info":[{"award-number":["NS112327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SUNY Research Seed Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-82927-1","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T20:10:46Z","timestamp":1735589446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ablation of lipocalin-2 reduces neuroinflammation in a mouse model of Krabbe disease"],"prefix":"10.1038","volume":"14","author":[{"given":"Jacob","family":"Favret","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malabika","family":"Maulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Masoom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devin","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daesung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"issue":"2","key":"82927_CR1","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1073\/pnas.66.2.302","volume":"66","author":"K Suzuki","year":"1970","unstructured":"Suzuki, K. & Suzuki, Y. Globoid cell leucodystrophy (Krabbe\u2019s disease): deficiency of galactocerebroside beta-galactosidase. Proc. Natl. Acad. Sci. USA  66 (2), 302\u2013309 (1970).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"82927_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","volume":"10","author":"DA Wenger","year":"1997","unstructured":"Wenger, D. A., Rafi, M. A. & Luzi, P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum. Mutat. 10 (4), 268\u2013279 (1997).","journal-title":"Hum. Mutat."},{"issue":"40","key":"82927_CR3","doi-asserted-by":"publisher","first-page":"20097","DOI":"10.1073\/pnas.1912108116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proc. Natl. Acad. Sci. USA  116 (40), 20097\u201320103 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"82927_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1023\/A:1022436928925","volume":"23","author":"K Suzuki","year":"1998","unstructured":"Suzuki, K. Twenty five years of the psychosine hypothesis: a personal perspective of its history and present status. Neurochem. Res. 23 (3), 251\u2013259 (1998).","journal-title":"Neurochem Res."},{"issue":"10","key":"82927_CR5","first-page":"2208","volume":"21","author":"S Komatsuzaki","year":"2019","unstructured":"Komatsuzaki, S. et al. Clinical characteristics of 248 patients with Krabbe disease: quantitative natural history modeling based on published cases. Genet. Sci. 21 (10), 2208\u20132215 (2019).","journal-title":"Genet. Sci."},{"issue":"10","key":"82927_CR6","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/glia.24008","volume":"69","author":"ML Feltri","year":"2021","unstructured":"Feltri, M. L. et al. Mechanisms of demyelination and neurodegeneration in globoid cell leukodystrophy. Glia 69 (10), 2309\u20132331 (2021).","journal-title":"Glia"},{"issue":"7","key":"82927_CR7","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.ymthe.2024.05.019","volume":"32","author":"J Favret","year":"2024","unstructured":"Favret, J. et al. Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice. Mol. Ther. 32 (7), 2207\u20132222 (2024).","journal-title":"Mol. Ther."},{"issue":"7019","key":"82927_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03104","volume":"432","author":"TH Flo","year":"2004","unstructured":"Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (7019), 917\u2013921 (2004).","journal-title":"Nature"},{"issue":"3","key":"82927_CR9","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/s10072-021-05579-3","volume":"43","author":"M Xiong","year":"2022","unstructured":"Xiong, M. et al. Serum levels of lipocalin-2 in patients with Parkinson\u2019s disease. Neurol. Sci. 43 (3), 1755\u20131759 (2022).","journal-title":"Neurol. Sci."},{"issue":"1","key":"82927_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13195-021-00955-9","volume":"14","author":"P Hermann","year":"2022","unstructured":"Hermann, P. et al. Plasma lipocalin 2 in Alzheimer\u2019s disease: potential utility in the differential diagnosis and relationship with other biomarkers. Alzheimers Res. Ther. 14 (1), 9 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"82927_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2021.07.001","volume":"107","author":"PJW Naud\u00e9","year":"2021","unstructured":"Naud\u00e9, P. J. W. et al. Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer\u2019s disease dementia. Neurobiol. Aging  107, 1\u201310 (2021).","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"82927_CR12","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1212\/NXI.0000000000000191","volume":"3","author":"F Al Nimer","year":"2016","unstructured":"Al Nimer, F. et al. Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination. Neurol. Neuroimmunol. Neuroinflamm.  3 (1), e191 (2016).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm"},{"issue":"8","key":"82927_CR13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/hmg\/ddac299","volume":"32","author":"MB Cach\u00f3n-Gonz\u00e1lez","year":"2023","unstructured":"Cach\u00f3n-Gonz\u00e1lez, M. B. et al. Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disorders. Hum. Mol. Genet. 32 (8), 1361\u20131379 (2023).","journal-title":"Hum. Mol. Genet."},{"key":"82927_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.neubiorev.2014.12.006","volume":"49","author":"MK Jha","year":"2015","unstructured":"Jha, M. K. et al. Diverse functional roles of lipocalin-2 in the central nervous system. Neurosci. Biobehav Rev. 49, 135\u2013156 (2015).","journal-title":"Neurosci. Biobehav Rev."},{"issue":"1","key":"82927_CR15","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1038\/s41467-020-19179-w","volume":"11","author":"NI Weinstock","year":"2020","unstructured":"Weinstock, N. I. et al. Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease. Nat. Commun. 11 (1), 5356 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"82927_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/gene.10154","volume":"35","author":"NH Doerflinger","year":"2003","unstructured":"Doerflinger, N. H., Macklin, W. B. & Popko, B. Inducible site-specific recombination in myelinating cells. Genesis 35 (1), 63\u201372 (2003).","journal-title":"Genesis"},{"issue":"4","key":"82927_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1008942828960","volume":"8","author":"B Clausen","year":"1999","unstructured":"Clausen, B. et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgen. Res. 8 (4), 265\u2013277 (1999).","journal-title":"Transgenic Res."},{"issue":"3","key":"82927_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1095","volume":"33","author":"C Lappe-Siefke","year":"2003","unstructured":"Lappe-Siefke, C. et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33 (3), 366\u2013374 (2003).","journal-title":"Nat. Genet."},{"issue":"1","key":"82927_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2020.03.031","volume":"107","author":"N Weinstock","year":"2020","unstructured":"Weinstock, N. et al. Macrophages expressing GALC improve peripheral Krabbe Disease by a mechanism Independent of cross-correction. Neuron 107 (1), 65\u201381 (2020).","journal-title":"Neuron"},{"issue":"4","key":"82927_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (4), 402\u2013408 (2001).","journal-title":"Methods"},{"issue":"1","key":"82927_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jneumeth.2012.06.017","volume":"209","author":"TA Dincman","year":"2012","unstructured":"Dincman, T. A. et al. Isolation of cortical mouse oligodendrocyte precursor cells. J. Neurosci. Methods. 209 (1), 219\u2013226 (2012).","journal-title":"J. Neurosci. Methods"},{"issue":"3","key":"82927_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/glia.10274","volume":"44","author":"J Saura","year":"2003","unstructured":"Saura, J., Tusell, J. M. & Serratosa, J. High-yield isolation of murine microglia by mild trypsinization. Glia 44 (3), 183\u2013189 (2003).","journal-title":"Glia"},{"key":"82927_CR23","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/srep02116","volume":"3","author":"AD Kov\u00e1cs","year":"2013","unstructured":"Kov\u00e1cs, A. D. & Pearce, D. A. Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains. Sci. Rep. 3, 2116 (2013).","journal-title":"Sci. Rep."},{"issue":"10","key":"82927_CR24","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s12276-023-01098-7","volume":"55","author":"BK Jung","year":"2023","unstructured":"Jung, B. K. & Ryu, K. Y. Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis. Exp. Mol. Med. 55 (10), 2138\u20132146 (2023).","journal-title":"Exp. Mol. Med."},{"key":"82927_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pneurobio.2015.06.005","volume":"131","author":"AC Ferreira","year":"2015","unstructured":"Ferreira, A. C. et al. From the periphery to the brain: Lipocalin-2, a friend or foe? Prog. Neurobiol. 131, 120\u2013136 (2015).","journal-title":"Prog Neurobiol."},{"issue":"5","key":"82927_CR26","doi-asserted-by":"publisher","first-page":"e96997","DOI":"10.1371\/journal.pone.0096997","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Lipocalin 2 expression and secretion is highly regulated by metabolic stress, cytokines, and nutrients in adipocytes. PLoS One  9 (5), e96997 (2014).","journal-title":"PLoS One"},{"key":"82927_CR27","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.pneurobio.2016.08.001","volume":"144","author":"K Suk","year":"2016","unstructured":"Suk, K. Lipocalin-2 as a therapeutic target for brain injury: an astrocentric perspective. Prog Neurobiol. 144, 158\u2013172 (2016).","journal-title":"Prog Neurobiol."},{"issue":"1","key":"82927_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1523\/JNEUROSCI.5273-08.2009","volume":"29","author":"S Lee","year":"2009","unstructured":"Lee, S. et al. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J. Neurosci. 29 (1), 234\u2013249 (2009).","journal-title":"J. Neurosci."},{"issue":"10","key":"82927_CR29","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1073\/pnas.1218497110","volume":"110","author":"F Bi","year":"2013","unstructured":"Bi, F. et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc. Natl. Acad. Sci. USA 110 (10), 4069\u20134074 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"82927_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/svn-2016-000009","volume":"1","author":"H Shishido","year":"2016","unstructured":"Shishido, H. et al. Role of lipocalin 2 in intraventricular haemoglobin-induced brain injury. Stroke Vasc. Neurol. 1 (2), 37\u201343 (2016).","journal-title":"Stroke Vasc Neurol."},{"issue":"18","key":"82927_CR31","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian, J. L. et al. Genomic analysis of reactive astrogliosis. J. Neurosci. 32 (18), 6391\u20136410 (2012).","journal-title":"J. Neurosci."},{"issue":"3","key":"82927_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/0006-291X(72)90381-6","volume":"48","author":"T Miyatake","year":"1972","unstructured":"Miyatake, T. & Suzuki, K. Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem. Biophys. Res. Commun. 48 (3), 538\u2013543 (1972).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"82927_CR33","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1523\/JNEUROSCI.5597-08.2009","volume":"29","author":"AB White","year":"2009","unstructured":"White, A. B. et al. Psychosine accumulates in membrane microdomains in the brain of krabbe patients, disrupting the raft architecture. J. Neurosci. 29 (19), 6068\u20136077 (2009).","journal-title":"J. Neurosci."},{"issue":"1","key":"82927_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00401-011-0814-2","volume":"122","author":"LC Castelvetri","year":"2011","unstructured":"Castelvetri, L. C. et al. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease. Acta Neuropathol. 122 (1), 35\u201348 (2011).","journal-title":"Acta Neuropathol."},{"key":"82927_CR35","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.nbd.2014.02.012","volume":"66","author":"CA Teixeira","year":"2014","unstructured":"Teixeira, C. A. et al. Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe\u2019s disease. Neurobiol. Dis. 66, 92\u2013103 (2014).","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"82927_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/jnr.22564","volume":"89","author":"A White","year":"2011","unstructured":"White, A. et al. Persistence of psychosine in brain lipid rafts is a limiting factor in the therapeutic recovery of a mouse model for Krabbe disease. J. Neurosci. Res. 89 (3), 352\u2013364 (2011).","journal-title":"J. Neurosci. Res."},{"issue":"43","key":"82927_CR37","doi-asserted-by":"publisher","first-page":"13237","DOI":"10.1073\/pnas.1507579112","volume":"112","author":"L Sborgi","year":"2015","unstructured":"Sborgi, L. et al. Structure and assembly of the mouse ASC inflammasome by combined NMR spectroscopy and cryo-electron microscopy. Proc. Natl. Acad. Sci. USA  112 (43), 13237\u201313242 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"7","key":"82927_CR38","doi-asserted-by":"publisher","first-page":"e3001661","DOI":"10.1371\/journal.pbio.3001661","volume":"20","author":"C Kreher","year":"2022","unstructured":"Kreher, C. et al. Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration. PLoS Biol. 20 (7), e3001661 (2022).","journal-title":"PLoS Biol."},{"issue":"1","key":"82927_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40246-019-0191-9","volume":"13","author":"G Charkoftaki","year":"2019","unstructured":"Charkoftaki, G. et al. Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse mup cluster is result of an evolutionary bloom. Hum. Genom.  13 (1), 11 (2019).","journal-title":"Hum. Genomics"},{"key":"82927_CR40","doi-asserted-by":"publisher","first-page":"922534","DOI":"10.3389\/fcvm.2022.922534","volume":"9","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Lipocalin-2 in neutrophils induces ferroptosis in septic cardiac dysfunction via increasing labile iron pool of cardiomyocytes. Front. Cardiovasc. Med. 9, 922534 (2022).","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"82927_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan, H. F. et al. Ferroptosis: mechanisms and links with diseases. Signal. Transduct. Target. Ther. 6 (1), 49 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"82927_CR42","doi-asserted-by":"publisher","first-page":"175909142096268","DOI":"10.1177\/1759091420962681","volume":"12","author":"VT Cheli","year":"2020","unstructured":"Cheli, V. T. et al. Iron metabolism in oligodendrocytes and astrocytes, implications for myelination and remyelination. ASN Neuro. 12, 1759091420962681 (2020).","journal-title":"ASN Neuro"},{"issue":"1","key":"82927_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s12974-018-1372-5","volume":"15","author":"DW Dekens","year":"2018","unstructured":"Dekens, D. W. et al. Lipocalin 2 contributes to brain iron dysregulation but does not affect cognition, plaque load, and glial activation in the J20 Alzheimer mouse model. J. Neuroinflam.  15 (1), 330 (2018).","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"82927_CR44","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie, Y. et al. Ferroptosis: process and function. Cell. Death Differ. 23 (3), 369\u2013379 (2016).","journal-title":"Cell. Death Differ."},{"issue":"11\u201312","key":"82927_CR45","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","volume":"73","author":"JY Cao","year":"2016","unstructured":"Cao, J. Y. & Dixon, S. J. Mechanisms of ferroptosis. Cell. Mol. Life Sci. 73 (11\u201312), 2195\u20132209 (2016).","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"82927_CR46","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/glia.22342","volume":"60","author":"JL Berard","year":"2012","unstructured":"Berard, J. L. et al. Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia 60 (7), 1145\u20131159 (2012).","journal-title":"Glia"},{"issue":"24","key":"82927_CR47","doi-asserted-by":"publisher","first-page":"16773","DOI":"10.1074\/jbc.M113.542282","volume":"289","author":"Y Nam","year":"2014","unstructured":"Nam, Y. et al. Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. J. Biol. Chem. 289 (24), 16773\u201316789 (2014).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"82927_CR48","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0736-5748(94)90075-2","volume":"12","author":"S LeVine","year":"1994","unstructured":"LeVine, S., Wetzel, D. & Eilert, A. Neuropathology of twitcher mice: examination by histochemistry, immunohistochemistry, lectin histochemistry and Fourier transform infrared microspectroscopy. Int. J. Dev. Neurosci. 12 (4), 275\u2013288 (1994).","journal-title":"Int. J. Dev. Neurosci."},{"issue":"3","key":"82927_CR49","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/BF00293398","volume":"88","author":"M Taniike","year":"1994","unstructured":"Taniike, M. & Suzuki, K. Spacio-temporal progression of demyelination in twitcher mouse: with clinico-pathological correlation. Acta Neuropathol. 88 (3), 228\u2013236 (1994).","journal-title":"Acta Neuropathol."},{"issue":"21","key":"82927_CR50","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1093\/hmg\/dds313","volume":"21","author":"S Santambrogio","year":"2012","unstructured":"Santambrogio, S. et al. The galactocerebrosidase enzyme contributes to maintain a functional neurogenic niche during early post-natal CNS development. Hum. Mol. Genet. 21 (21), 4732\u20134750 (2012).","journal-title":"Hum. Mol. Genet."},{"issue":"17","key":"82927_CR51","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1093\/hmg\/ddt190","volume":"22","author":"GB Potter","year":"2013","unstructured":"Potter, G. B. et al. Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease. Hum. Mol. Genet. 22 (17), 3397\u20133414 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"82927_CR52","doi-asserted-by":"crossref","unstructured":"Snook, E. R. et al. Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy. Am. J. Pathol. 184 (2). (2014).","DOI":"10.1016\/j.ajpath.2013.10.011"},{"issue":"5","key":"82927_CR53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/glia.22471","volume":"61","author":"K Ijichi","year":"2013","unstructured":"Ijichi, K. et al. MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology. Glia 61 (5), 765\u2013777 (2013).","journal-title":"Glia"},{"issue":"16","key":"82927_CR54","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1523\/JNEUROSCI.4531-05.2006","volume":"26","author":"I Mohri","year":"2006","unstructured":"Mohri, I. et al. Prostaglandin D2-mediated microgliaastrocyte interaction enhances astrogliosis and demyelination in twitcher. J. Neurosci. 26 (16), 4383\u20134393 (2006).","journal-title":"J. Neurosci."},{"issue":"4","key":"82927_CR55","first-page":"1498","volume":"10","author":"MA Collart","year":"1990","unstructured":"Collart, M. A., Baeuerle, P. & Vassalli, P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10 (4), 1498\u20131506 (1990).","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"82927_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.171.1.35","volume":"171","author":"AN Shakhov","year":"1990","unstructured":"Shakhov, A. N. et al. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J. Exp. Med. 171 (1), 35\u201347 (1990).","journal-title":"J. Exp. Med."},{"issue":"5","key":"82927_CR57","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.4049\/jimmunol.153.5.2052","volume":"153","author":"A Ueda","year":"1994","unstructured":"Ueda, A. et al. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J. Immunol. 153 (5), 2052\u20132063 (1994).","journal-title":"J. Immunol."},{"issue":"1","key":"82927_CR58","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbrc.2004.02.030","volume":"316","author":"RC Borghaei","year":"2004","unstructured":"Borghaei, R. C. et al. NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem. Biophys. Res. Commun. 316 (1), 182\u2013188 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"82927_CR59","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/j.1460-2075.1993.tb05850.x","volume":"12","author":"M Meyer","year":"1993","unstructured":"Meyer, M., Schreck, R. & Baeuerle, P. A. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. Embo j. 12 (5), 2005\u20132015 (1993).","journal-title":"Embo j."},{"issue":"3","key":"82927_CR60","doi-asserted-by":"publisher","first-page":"G719","DOI":"10.1152\/ajpgi.00108.2002","volume":"283","author":"H She","year":"2002","unstructured":"She, H. et al. Iron activates NF-kappaB in Kupffer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (3), G719\u2013G726 (2002).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"82927_CR61","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1096\/fj.12-222257","volume":"27","author":"E Jang","year":"2013","unstructured":"Jang, E. et al. Secreted protein lipocalin-2 promotes microglial M1 polarization. Faseb J. 27 (3), 1176\u20131190 (2013).","journal-title":"Faseb j."},{"issue":"10","key":"82927_CR62","doi-asserted-by":"publisher","first-page":"5204","DOI":"10.4049\/jimmunol.1301637","volume":"191","author":"E Jang","year":"2013","unstructured":"Jang, E. et al. Phenotypic polarization of activated astrocytes: the critical role of lipocalin-2 in the classical inflammatory activation of astrocytes. J. Immunol. 191 (10), 5204\u20135219 (2013).","journal-title":"J. Immunol."},{"issue":"3","key":"82927_CR63","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s13311-022-01333-5","volume":"20","author":"JH Kim","year":"2023","unstructured":"Kim, J. H. et al. Lipocalin-2 is a Key Regulator of Neuroinflammation in secondary traumatic and ischemic brain Injury. Neurotherapeutics 20 (3), 803\u2013821 (2023).","journal-title":"Neurotherapeutics"},{"issue":"1","key":"82927_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-2094-2-10","volume":"2","author":"K Kagitani-Shimono","year":"2005","unstructured":"Kagitani-Shimono, K. et al. Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model. J. Neuroinflamm. 2 (1), 10 (2005).","journal-title":"J. Neuroinflamm."},{"key":"82927_CR65","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1242\/jcs.169342","volume":"128","author":"C O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan, C. & Dev, K. K. Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. J. Cell. Sci. 128, 3878\u20133887 (2015).","journal-title":"J. Cell. Sci."},{"issue":"15","key":"82927_CR66","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1523\/JNEUROSCI.2346-19.2020","volume":"40","author":"S B\u00e9chet","year":"2020","unstructured":"B\u00e9chet, S. et al. Fingolimod rescues demyelination in a mouse model of Krabbe\u2019s disease. J. Neurosci. 40 (15), 3104\u20133118 (2020).","journal-title":"J. Neurosci."},{"issue":"11","key":"82927_CR67","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1002\/jnr.23822","volume":"94","author":"CR Mikulka","year":"2016","unstructured":"Mikulka, C. R. & Sands, M. S. Treatment for Krabbe\u2019s disease: finding the combination. J. Neurosci. Res. 94 (11), 1126\u20131137 (2016).","journal-title":"J. Neurosci. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82927-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82927-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T21:06:51Z","timestamp":1735592811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-82927-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["82927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-82927-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31822"}}